fig3

Overcoming cancer drug resistance through small-molecule targeting of HSP90 and HSP70

Figure 3. Representative chemical structures of HSP70 inhibitors. These compounds also show potential in drug-resistant cancers. SHetA2 is the only one in a clinical trial. This figure was generated by the ChemDraw Software (V 2020). HSP: Heat shock protein; SHetA2: sulfur heteroarotinoid A2.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/